Latest news from SEQENS Group

All news

Events General General PERSONAL CARE Press release Products & Technologies Protéus SD-CSR

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

European Industry Summit: Pierre Luzeau, CEO of Seqens joins 73 industry leaders to call for a European Industrial Deal

Seqens and KK India petroleum specialties PVT LTD announce new partnership for lubricant additives in India

Products & Technologies

Skinification: plant polysaccharides rescue damaged hair

Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis

Seqens confirms the acquisition of CELLforCURE

New investments in China

Seqens group at DCAT Week 2023

Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston

Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.

DCAT 2022: a success for Seqens group

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory

Meeting with Virginie Tarlet for the International Women’s Day

1 2 3 4 … 11

Contact